SBFM: Sunshine Biopharma, Inc. Stock

by  •  • Comments Off on SBFM: Sunshine Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.30
Enterprise Value ($M) -6.37
Book Value ($M) 23.50
Book Value / Share 6.46
Price / Book 0.14
NCAV ($M) 18.91
NCAV / Share 5.20
Price / NCAV 0.17

Profitability (mra)
Return on Invested Capital (ROIC) -0.21
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.21

Liquidity (mrq)
Quick Ratio 2.33
Current Ratio 4.11

Balance Sheet (mrq) ($M)
Current Assets 25.97
Assets 30.56
Liabilities 7.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 34.87
Operating Income -5.81
Net Income -5.13
Earnings Per Share Policy Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.53
Cash from Investing -2.32
Cash from Financing 9.29

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
8 days ago 13G Bigger Capital Fund L P 8.17
11-14 13G/A Armistice Capital, Llc 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 37,895 101,325 37.40
2025-04-16 28,641 109,505 26.15
2025-04-15 27,541 109,158 25.23
2025-04-14 27,524 112,415 24.48

(click for more detail)

Similar Companies
RZLT – Rezolute, Inc. SABS – SAB Biotherapeutics, Inc.
SAVA – Cassava Sciences, Inc. SCLX – Scilex Holding Company
SGMO – Sangamo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io